Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:09 AM
Ignite Modification Date:
2025-12-26 @ 11:09 AM
NCT ID:
NCT07046312
Eligibility Criteria:
Inclusion Criteria:
* Psoriatic arthritis patients according to CASPAR criteria
* Psoriatic arthritis patients without overt cardiovascular symptoms
* Patients with age between 20 to 50 years of age
Exclusion Criteria:
* Other systemic autoimmune diseases
* Patients with a history of known valvular disease, atrial fibrillation or any other arrhythmia , heart failure, ischemic cardiomyopathy severe obstructive pulmonary diseases and metabolic syndrome.
* Patients with medical disorders as renal, congenital heart diseases, hematological disorders and cancer patients.
* Patients taking certain drugs that have been confirmed to be risk factors for PAH such as appetite suppressant intake drugs (aminorex, fenfluramine derivatives and benfluorex) and chemotherapeutic agents.
* Family history of myocardial infarction, cerebrovascular disease or sudden death before the age of 65y in females and 55 y in males.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
50 Years
Study:
NCT07046312
Study Brief:
Protocol Section:
NCT07046312